ribavirin has been researched along with Chronic Delta Hepatitis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biziya, N; Gidaagaya, S; Namdag, B; Yang, SS | 1 |
Gonzalez, SA; Keeffe, EB | 1 |
Drenth, JP; Heidrich, B; Kirgiz, ÖÖ; Lamers, MH; Wedemeyer, H | 1 |
Akarca, US; Batur, Y; Ersoz, G; Gunsar, F; Ilter, T; Karasu, Z; Kobak, AC; Yuce, G | 1 |
Andriulli, A; Brancaccio, G; Ciancio, A; David, E; Fontana, R; Gaeta, GB; Marrone, A; Niro, GA; Olivero, A; Perri, F; Rizzetto, M; Smedile, A; Stanzione, M | 1 |
Buffet, C | 1 |
Böker, KH; Manns, MP | 1 |
4 review(s) available for ribavirin and Chronic Delta Hepatitis
Article | Year |
---|---|
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials.
Topics: Alanine Transaminase; Antiviral Agents; Databases, Factual; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Lamivudine; Randomized Controlled Trials as Topic; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome | 2012 |
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases | 2006 |
[Therapy of chronic viral hepatitis].
Topics: Antiviral Agents; Germany; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Liver Transplantation; Prognosis; Renal Dialysis; Ribavirin; Risk Factors | 1999 |
2 trial(s) available for ribavirin and Chronic Delta Hepatitis
Article | Year |
---|---|
Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome | 2005 |
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.
Topics: Adult; Antiviral Agents; Biopsy; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
1 other study(ies) available for ribavirin and Chronic Delta Hepatitis
Article | Year |
---|---|
Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene.
Topics: Bilirubin; Female; Glucuronosyltransferase; Hepatitis D, Chronic; Humans; Hyperbilirubinemia; Interferons; Male; Middle Aged; Ribavirin; Young Adult | 2015 |